Request for Covid-19 Impact Assessment of this Report
The United States Decongestant market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Decongestant market, reaching US$ million by the year 2028. As for the Europe Decongestant landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Decongestant players cover Mylan N.V., Teva Pharmaceutical Industries Ltd., Ranbaxy Laboratories Ltd., and Beximco Pharmaceuticals Ltd., etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Decongestant market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Tablets
Capsules
Nasal Sprays
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospitals
Research & Academic Laboratories
Clinic
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Mylan N.V.
Teva Pharmaceutical Industries Ltd.
Ranbaxy Laboratories Ltd.
Beximco Pharmaceuticals Ltd.
Novartis AG
Cipla Ltd.
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Decongestant Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Decongestant by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Decongestant by Country/Region, 2017, 2022 & 2028
2.2 Decongestant Segment by Type
2.2.1 Tablets
2.2.2 Capsules
2.2.3 Nasal Sprays
2.3 Decongestant Sales by Type
2.3.1 Global Decongestant Sales Market Share by Type (2017-2022)
2.3.2 Global Decongestant Revenue and Market Share by Type (2017-2022)
2.3.3 Global Decongestant Sale Price by Type (2017-2022)
2.4 Decongestant Segment by Application
2.4.1 Hospitals
2.4.2 Research & Academic Laboratories
2.4.3 Clinic
2.4.4 Other
2.5 Decongestant Sales by Application
2.5.1 Global Decongestant Sale Market Share by Application (2017-2022)
2.5.2 Global Decongestant Revenue and Market Share by Application (2017-2022)
2.5.3 Global Decongestant Sale Price by Application (2017-2022)
3 Global Decongestant by Company
3.1 Global Decongestant Breakdown Data by Company
3.1.1 Global Decongestant Annual Sales by Company (2020-2022)
3.1.2 Global Decongestant Sales Market Share by Company (2020-2022)
3.2 Global Decongestant Annual Revenue by Company (2020-2022)
3.2.1 Global Decongestant Revenue by Company (2020-2022)
3.2.2 Global Decongestant Revenue Market Share by Company (2020-2022)
3.3 Global Decongestant Sale Price by Company
3.4 Key Manufacturers Decongestant Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Decongestant Product Location Distribution
3.4.2 Players Decongestant Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Decongestant by Geographic Region
4.1 World Historic Decongestant Market Size by Geographic Region (2017-2022)
4.1.1 Global Decongestant Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Decongestant Annual Revenue by Geographic Region
4.2 World Historic Decongestant Market Size by Country/Region (2017-2022)
4.2.1 Global Decongestant Annual Sales by Country/Region (2017-2022)
4.2.2 Global Decongestant Annual Revenue by Country/Region
4.3 Americas Decongestant Sales Growth
4.4 APAC Decongestant Sales Growth
4.5 Europe Decongestant Sales Growth
4.6 Middle East & Africa Decongestant Sales Growth
5 Americas
5.1 Americas Decongestant Sales by Country
5.1.1 Americas Decongestant Sales by Country (2017-2022)
5.1.2 Americas Decongestant Revenue by Country (2017-2022)
5.2 Americas Decongestant Sales by Type
5.3 Americas Decongestant Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Decongestant Sales by Region
6.1.1 APAC Decongestant Sales by Region (2017-2022)
6.1.2 APAC Decongestant Revenue by Region (2017-2022)
6.2 APAC Decongestant Sales by Type
6.3 APAC Decongestant Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Decongestant by Country
7.1.1 Europe Decongestant Sales by Country (2017-2022)
7.1.2 Europe Decongestant Revenue by Country (2017-2022)
7.2 Europe Decongestant Sales by Type
7.3 Europe Decongestant Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Decongestant by Country
8.1.1 Middle East & Africa Decongestant Sales by Country (2017-2022)
8.1.2 Middle East & Africa Decongestant Revenue by Country (2017-2022)
8.2 Middle East & Africa Decongestant Sales by Type
8.3 Middle East & Africa Decongestant Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Decongestant
10.3 Manufacturing Process Analysis of Decongestant
10.4 Industry Chain Structure of Decongestant
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Decongestant Distributors
11.3 Decongestant Customer
12 World Forecast Review for Decongestant by Geographic Region
12.1 Global Decongestant Market Size Forecast by Region
12.1.1 Global Decongestant Forecast by Region (2023-2028)
12.1.2 Global Decongestant Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Decongestant Forecast by Type
12.7 Global Decongestant Forecast by Application
13 Key Players Analysis
13.1 Mylan N.V.
13.1.1 Mylan N.V. Company Information
13.1.2 Mylan N.V. Decongestant Product Offered
13.1.3 Mylan N.V. Decongestant Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Mylan N.V. Main Business Overview
13.1.5 Mylan N.V. Latest Developments
13.2 Teva Pharmaceutical Industries Ltd.
13.2.1 Teva Pharmaceutical Industries Ltd. Company Information
13.2.2 Teva Pharmaceutical Industries Ltd. Decongestant Product Offered
13.2.3 Teva Pharmaceutical Industries Ltd. Decongestant Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Teva Pharmaceutical Industries Ltd. Main Business Overview
13.2.5 Teva Pharmaceutical Industries Ltd. Latest Developments
13.3 Ranbaxy Laboratories Ltd.
13.3.1 Ranbaxy Laboratories Ltd. Company Information
13.3.2 Ranbaxy Laboratories Ltd. Decongestant Product Offered
13.3.3 Ranbaxy Laboratories Ltd. Decongestant Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Ranbaxy Laboratories Ltd. Main Business Overview
13.3.5 Ranbaxy Laboratories Ltd. Latest Developments
13.4 Beximco Pharmaceuticals Ltd.
13.4.1 Beximco Pharmaceuticals Ltd. Company Information
13.4.2 Beximco Pharmaceuticals Ltd. Decongestant Product Offered
13.4.3 Beximco Pharmaceuticals Ltd. Decongestant Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Beximco Pharmaceuticals Ltd. Main Business Overview
13.4.5 Beximco Pharmaceuticals Ltd. Latest Developments
13.5 Novartis AG
13.5.1 Novartis AG Company Information
13.5.2 Novartis AG Decongestant Product Offered
13.5.3 Novartis AG Decongestant Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Novartis AG Main Business Overview
13.5.5 Novartis AG Latest Developments
13.6 Cipla Ltd.
13.6.1 Cipla Ltd. Company Information
13.6.2 Cipla Ltd. Decongestant Product Offered
13.6.3 Cipla Ltd. Decongestant Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Cipla Ltd. Main Business Overview
13.6.5 Cipla Ltd. Latest Developments
14 Research Findings and Conclusion
Table 1. Decongestant Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Decongestant Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Tablets
Table 4. Major Players of Capsules
Table 5. Major Players of Nasal Sprays
Table 6. Global Decongestant Sales by Type (2017-2022) & (MT)
Table 7. Global Decongestant Sales Market Share by Type (2017-2022)
Table 8. Global Decongestant Revenue by Type (2017-2022) & ($ million)
Table 9. Global Decongestant Revenue Market Share by Type (2017-2022)
Table 10. Global Decongestant Sale Price by Type (2017-2022) & (USD/Kg)
Table 11. Global Decongestant Sales by Application (2017-2022) & (MT)
Table 12. Global Decongestant Sales Market Share by Application (2017-2022)
Table 13. Global Decongestant Revenue by Application (2017-2022)
Table 14. Global Decongestant Revenue Market Share by Application (2017-2022)
Table 15. Global Decongestant Sale Price by Application (2017-2022) & (USD/Kg)
Table 16. Global Decongestant Sales by Company (2020-2022) & (MT)
Table 17. Global Decongestant Sales Market Share by Company (2020-2022)
Table 18. Global Decongestant Revenue by Company (2020-2022) ($ Millions)
Table 19. Global Decongestant Revenue Market Share by Company (2020-2022)
Table 20. Global Decongestant Sale Price by Company (2020-2022) & (USD/Kg)
Table 21. Key Manufacturers Decongestant Producing Area Distribution and Sales Area
Table 22. Players Decongestant Products Offered
Table 23. Decongestant Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Decongestant Sales by Geographic Region (2017-2022) & (MT)
Table 27. Global Decongestant Sales Market Share Geographic Region (2017-2022)
Table 28. Global Decongestant Revenue by Geographic Region (2017-2022) & ($ millions)
Table 29. Global Decongestant Revenue Market Share by Geographic Region (2017-2022)
Table 30. Global Decongestant Sales by Country/Region (2017-2022) & (MT)
Table 31. Global Decongestant Sales Market Share by Country/Region (2017-2022)
Table 32. Global Decongestant Revenue by Country/Region (2017-2022) & ($ millions)
Table 33. Global Decongestant Revenue Market Share by Country/Region (2017-2022)
Table 34. Americas Decongestant Sales by Country (2017-2022) & (MT)
Table 35. Americas Decongestant Sales Market Share by Country (2017-2022)
Table 36. Americas Decongestant Revenue by Country (2017-2022) & ($ Millions)
Table 37. Americas Decongestant Revenue Market Share by Country (2017-2022)
Table 38. Americas Decongestant Sales by Type (2017-2022) & (MT)
Table 39. Americas Decongestant Sales Market Share by Type (2017-2022)
Table 40. Americas Decongestant Sales by Application (2017-2022) & (MT)
Table 41. Americas Decongestant Sales Market Share by Application (2017-2022)
Table 42. APAC Decongestant Sales by Region (2017-2022) & (MT)
Table 43. APAC Decongestant Sales Market Share by Region (2017-2022)
Table 44. APAC Decongestant Revenue by Region (2017-2022) & ($ Millions)
Table 45. APAC Decongestant Revenue Market Share by Region (2017-2022)
Table 46. APAC Decongestant Sales by Type (2017-2022) & (MT)
Table 47. APAC Decongestant Sales Market Share by Type (2017-2022)
Table 48. APAC Decongestant Sales by Application (2017-2022) & (MT)
Table 49. APAC Decongestant Sales Market Share by Application (2017-2022)
Table 50. Europe Decongestant Sales by Country (2017-2022) & (MT)
Table 51. Europe Decongestant Sales Market Share by Country (2017-2022)
Table 52. Europe Decongestant Revenue by Country (2017-2022) & ($ Millions)
Table 53. Europe Decongestant Revenue Market Share by Country (2017-2022)
Table 54. Europe Decongestant Sales by Type (2017-2022) & (MT)
Table 55. Europe Decongestant Sales Market Share by Type (2017-2022)
Table 56. Europe Decongestant Sales by Application (2017-2022) & (MT)
Table 57. Europe Decongestant Sales Market Share by Application (2017-2022)
Table 58. Middle East & Africa Decongestant Sales by Country (2017-2022) & (MT)
Table 59. Middle East & Africa Decongestant Sales Market Share by Country (2017-2022)
Table 60. Middle East & Africa Decongestant Revenue by Country (2017-2022) & ($ Millions)
Table 61. Middle East & Africa Decongestant Revenue Market Share by Country (2017-2022)
Table 62. Middle East & Africa Decongestant Sales by Type (2017-2022) & (MT)
Table 63. Middle East & Africa Decongestant Sales Market Share by Type (2017-2022)
Table 64. Middle East & Africa Decongestant Sales by Application (2017-2022) & (MT)
Table 65. Middle East & Africa Decongestant Sales Market Share by Application (2017-2022)
Table 66. Key Market Drivers & Growth Opportunities of Decongestant
Table 67. Key Market Challenges & Risks of Decongestant
Table 68. Key Industry Trends of Decongestant
Table 69. Decongestant Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Decongestant Distributors List
Table 72. Decongestant Customer List
Table 73. Global Decongestant Sales Forecast by Region (2023-2028) & (MT)
Table 74. Global Decongestant Sales Market Forecast by Region
Table 75. Global Decongestant Revenue Forecast by Region (2023-2028) & ($ millions)
Table 76. Global Decongestant Revenue Market Share Forecast by Region (2023-2028)
Table 77. Americas Decongestant Sales Forecast by Country (2023-2028) & (MT)
Table 78. Americas Decongestant Revenue Forecast by Country (2023-2028) & ($ millions)
Table 79. APAC Decongestant Sales Forecast by Region (2023-2028) & (MT)
Table 80. APAC Decongestant Revenue Forecast by Region (2023-2028) & ($ millions)
Table 81. Europe Decongestant Sales Forecast by Country (2023-2028) & (MT)
Table 82. Europe Decongestant Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. Middle East & Africa Decongestant Sales Forecast by Country (2023-2028) & (MT)
Table 84. Middle East & Africa Decongestant Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Global Decongestant Sales Forecast by Type (2023-2028) & (MT)
Table 86. Global Decongestant Sales Market Share Forecast by Type (2023-2028)
Table 87. Global Decongestant Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 88. Global Decongestant Revenue Market Share Forecast by Type (2023-2028)
Table 89. Global Decongestant Sales Forecast by Application (2023-2028) & (MT)
Table 90. Global Decongestant Sales Market Share Forecast by Application (2023-2028)
Table 91. Global Decongestant Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 92. Global Decongestant Revenue Market Share Forecast by Application (2023-2028)
Table 93. Mylan N.V. Basic Information, Decongestant Manufacturing Base, Sales Area and Its Competitors
Table 94. Mylan N.V. Decongestant Product Offered
Table 95. Mylan N.V. Decongestant Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 96. Mylan N.V. Main Business
Table 97. Mylan N.V. Latest Developments
Table 98. Teva Pharmaceutical Industries Ltd. Basic Information, Decongestant Manufacturing Base, Sales Area and Its Competitors
Table 99. Teva Pharmaceutical Industries Ltd. Decongestant Product Offered
Table 100. Teva Pharmaceutical Industries Ltd. Decongestant Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 101. Teva Pharmaceutical Industries Ltd. Main Business
Table 102. Teva Pharmaceutical Industries Ltd. Latest Developments
Table 103. Ranbaxy Laboratories Ltd. Basic Information, Decongestant Manufacturing Base, Sales Area and Its Competitors
Table 104. Ranbaxy Laboratories Ltd. Decongestant Product Offered
Table 105. Ranbaxy Laboratories Ltd. Decongestant Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 106. Ranbaxy Laboratories Ltd. Main Business
Table 107. Ranbaxy Laboratories Ltd. Latest Developments
Table 108. Beximco Pharmaceuticals Ltd. Basic Information, Decongestant Manufacturing Base, Sales Area and Its Competitors
Table 109. Beximco Pharmaceuticals Ltd. Decongestant Product Offered
Table 110. Beximco Pharmaceuticals Ltd. Decongestant Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 111. Beximco Pharmaceuticals Ltd. Main Business
Table 112. Beximco Pharmaceuticals Ltd. Latest Developments
Table 113. Novartis AG Basic Information, Decongestant Manufacturing Base, Sales Area and Its Competitors
Table 114. Novartis AG Decongestant Product Offered
Table 115. Novartis AG Decongestant Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 116. Novartis AG Main Business
Table 117. Novartis AG Latest Developments
Table 118. Cipla Ltd. Basic Information, Decongestant Manufacturing Base, Sales Area and Its Competitors
Table 119. Cipla Ltd. Decongestant Product Offered
Table 120. Cipla Ltd. Decongestant Sales (MT), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2020-2022)
Table 121. Cipla Ltd. Main Business
Table 122. Cipla Ltd. Latest Developments
List of Figures
Figure 1. Picture of Decongestant
Figure 2. Decongestant Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Decongestant Sales Growth Rate 2017-2028 (MT)
Figure 7. Global Decongestant Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Decongestant Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Tablets
Figure 10. Product Picture of Capsules
Figure 11. Product Picture of Nasal Sprays
Figure 12. Global Decongestant Sales Market Share by Type in 2021
Figure 13. Global Decongestant Revenue Market Share by Type (2017-2022)
Figure 14. Decongestant Consumed in Hospitals
Figure 15. Global Decongestant Market: Hospitals (2017-2022) & (MT)
Figure 16. Decongestant Consumed in Research & Academic Laboratories
Figure 17. Global Decongestant Market: Research & Academic Laboratories (2017-2022) & (MT)
Figure 18. Decongestant Consumed in Clinic
Figure 19. Global Decongestant Market: Clinic (2017-2022) & (MT)
Figure 20. Decongestant Consumed in Other
Figure 21. Global Decongestant Market: Other (2017-2022) & (MT)
Figure 22. Global Decongestant Sales Market Share by Application (2017-2022)
Figure 23. Global Decongestant Revenue Market Share by Application in 2021
Figure 24. Decongestant Revenue Market by Company in 2021 ($ Million)
Figure 25. Global Decongestant Revenue Market Share by Company in 2021
Figure 26. Global Decongestant Sales Market Share by Geographic Region (2017-2022)
Figure 27. Global Decongestant Revenue Market Share by Geographic Region in 2021
Figure 28. Global Decongestant Sales Market Share by Region (2017-2022)
Figure 29. Global Decongestant Revenue Market Share by Country/Region in 2021
Figure 30. Americas Decongestant Sales 2017-2022 (MT)
Figure 31. Americas Decongestant Revenue 2017-2022 ($ Millions)
Figure 32. APAC Decongestant Sales 2017-2022 (MT)
Figure 33. APAC Decongestant Revenue 2017-2022 ($ Millions)
Figure 34. Europe Decongestant Sales 2017-2022 (MT)
Figure 35. Europe Decongestant Revenue 2017-2022 ($ Millions)
Figure 36. Middle East & Africa Decongestant Sales 2017-2022 (MT)
Figure 37. Middle East & Africa Decongestant Revenue 2017-2022 ($ Millions)
Figure 38. Americas Decongestant Sales Market Share by Country in 2021
Figure 39. Americas Decongestant Revenue Market Share by Country in 2021
Figure 40. United States Decongestant Revenue Growth 2017-2022 ($ Millions)
Figure 41. Canada Decongestant Revenue Growth 2017-2022 ($ Millions)
Figure 42. Mexico Decongestant Revenue Growth 2017-2022 ($ Millions)
Figure 43. Brazil Decongestant Revenue Growth 2017-2022 ($ Millions)
Figure 44. APAC Decongestant Sales Market Share by Region in 2021
Figure 45. APAC Decongestant Revenue Market Share by Regions in 2021
Figure 46. China Decongestant Revenue Growth 2017-2022 ($ Millions)
Figure 47. Japan Decongestant Revenue Growth 2017-2022 ($ Millions)
Figure 48. South Korea Decongestant Revenue Growth 2017-2022 ($ Millions)
Figure 49. Southeast Asia Decongestant Revenue Growth 2017-2022 ($ Millions)
Figure 50. India Decongestant Revenue Growth 2017-2022 ($ Millions)
Figure 51. Australia Decongestant Revenue Growth 2017-2022 ($ Millions)
Figure 52. Europe Decongestant Sales Market Share by Country in 2021
Figure 53. Europe Decongestant Revenue Market Share by Country in 2021
Figure 54. Germany Decongestant Revenue Growth 2017-2022 ($ Millions)
Figure 55. France Decongestant Revenue Growth 2017-2022 ($ Millions)
Figure 56. UK Decongestant Revenue Growth 2017-2022 ($ Millions)
Figure 57. Italy Decongestant Revenue Growth 2017-2022 ($ Millions)
Figure 58. Russia Decongestant Revenue Growth 2017-2022 ($ Millions)
Figure 59. Middle East & Africa Decongestant Sales Market Share by Country in 2021
Figure 60. Middle East & Africa Decongestant Revenue Market Share by Country in 2021
Figure 61. Egypt Decongestant Revenue Growth 2017-2022 ($ Millions)
Figure 62. South Africa Decongestant Revenue Growth 2017-2022 ($ Millions)
Figure 63. Israel Decongestant Revenue Growth 2017-2022 ($ Millions)
Figure 64. Turkey Decongestant Revenue Growth 2017-2022 ($ Millions)
Figure 65. GCC Country Decongestant Revenue Growth 2017-2022 ($ Millions)
Figure 66. Manufacturing Cost Structure Analysis of Decongestant in 2021
Figure 67. Manufacturing Process Analysis of Decongestant
Figure 68. Industry Chain Structure of Decongestant
Figure 69. Channels of Distribution
Figure 70. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...